The Australia laboratory centrifuge market size reached USD 50.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 68.7 Million by 2033, exhibiting a growth rate (CAGR) of 3.20% during 2025-2033. The market is driven by the rise in infectious and chronic diseases throughout Australia, heightened focus on government grants, university partnerships, and investments, and increasing need for operation efficiency and quality assurance in labs.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 50.1 Million |
Market Forecast in 2033 | USD 68.7 Million |
Market Growth Rate 2025-2033 | 3.20% |
Growing Demand for Diagnostic and Clinical Testing Services
The rise in infectious and chronic diseases throughout Australia is contributing to greater dependency on pathology services and diagnostic laboratories, significantly driving the demand for laboratory centrifuges. With the healthcare industry emphasizing early disease identification and tailored treatment, centrifugation continues to play a key role in separating blood components, identifying pathogens, and analyzing bodily fluids with accuracy. Government initiatives to develop diagnostic infrastructure, especially in rural and underserved communities, further drive this trend. Furthermore, the increasing adoption of sophisticated diagnostic technologies, like liquid biopsy and molecular diagnostics, demands high-speed and high-throughput centrifuge equipment. Public and private diagnostic laboratories' expansion, fueled by Australia's increasing aging population and higher health awareness, is also supporting the procurement of advanced laboratory equipment, including benchtop and floor-standing centrifuges. In 2024, more than 2.1 million people were aged 75 and over in Australia and the number is projected to increase 3.2 million by 2032.
Expansion of Biotechnology and Pharmaceutical Research Activities
Australia's pharmaceutical and biotechnology industries are experiencing strong growth through government grants, university partnerships, and escalating world investment. Laboratory centrifuges are essential equipment in research and development (R&D) operations, especially in cell culture processing, protein analysis, drug development, and genomic research. With biotech companies emphasizing innovation in therapeutics, vaccines, and biologics, there is greater demand for accurate equipment that can handle fragile biological samples. The financial support by the Australian Government through grants, tax benefits, and the Medical Research Future Fund (MRFF) stimulates large-scale research, resulting in the establishment and growth of laboratory facilities with sophisticated centrifugation machines. In addition, the development of contract research organizations (CROs) providing value-added analytical and testing services is driving the demand for centrifuges. These organizations need high-performance centrifuges to execute efficient, scalable, and reproducible processes, also driving the market. As per the statement of the IMARC Group, the Australia biotechnology market size is expected to reach USD 23.42 Billion by 2032.
Technological Advancements and Automation in Laboratory Equipment
Innovations in technology are greatly boosting the performance capabilities of contemporary laboratory centrifuges to become more friendly, efficient, and compatible with high-throughput work. Computer-controlled centrifuge systems with program-enabled features, embedded safety protocols, and electronic control interfaces are widely sought by clinical and research labs in Australia. These systems eliminate human intervention, enhance reliability, and are time-saving, complementing increased need for operation efficiency and quality assurance. In addition, innovations in rotor technology, noise-suppressing techniques, and power-saving designs cater to green laboratory practices, ever more crucial with Australia's new environmental regulations. Connectivity to Internet of Things (IoT) platforms enable real-time monitoring and logging, improving traceability and compatibility with standards. The Australian IoT market is expected to reach USD 90.61 Billion by 2032, according to the data of the IMARC Group.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on Product type, model type, rotor design, intended use, application, and end-user.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes equipment (multipurpose centrifuges, microcentrifuges, ultracentrifuges, minicentrifuges, and others) and accessories (rotors, tubes, centrifuge bottles, buckets, plates, and others).
Model Type Insights:
A detailed breakup and analysis of the market based on the model type have also been provided in the report. This includes benchtop centrifuges and floor-standing centrifuges.
Rotor Design Insights:
A detailed breakup and analysis of the market based on the rotor design have also been provided in the report. This includes fixed-angle rotors, swinging-bucket rotors, vertical rotors, and others.
Intended Use Insights:
A detailed breakup and analysis of the market based on the intended use have also been provided in the report. This includes general purpose centrifuges, clinical centrifuges, and preclinical centrifuges.
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes diagnostics, microbiology, cellomics, genomics, proteomics, blood component separation, and others.
End-User Insights:
A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes hospitals, biotechnology and pharmaceutical companies, and academic and research institutions.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, northern territory & southern Australia, and western Australia.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered |
|
Model Types Covered | Benchtop Centrifuges, Floor-Standing Centrifuges |
Rotor Designs Covered | Fixed-Angle Rotors, Swinging-Bucket Rotors, Vertical Rotors, Others |
Intended Uses Covered | General Purpose Centrifuges, Clinical Centrifuges, Preclinical Centrifuges |
Applications Covered | Diagnostics, Microbiology, Cellomics, Genomics, Proteomics, Blood Component Separation, Others |
End-Users Covered | Hospitals, Biotechnology and Pharmaceutical Companies, Academic and Research Institutions |
Regions Covered | Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, Western Australia |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: